Chief Scientific Officer at Integrated Bio Bank of Luxembourg. 

Dr Betsou is a molecular biologist with 25 years of experience in molecular diagnostics, disease-oriented biobanking and biospecimen research, and 18 years of experience in ISO 9001 and ISO 17025 application to biobanks.

Department of Pathology, BC Cancer Agency, University of British Columbia, Canada.

Professor Watson is the Director of Biobanking and Biospecimen Research Services (BBRS) which is a research infrastructure group that encompasses an active biobank (Tumour Tissue Repository) and a biobanking support unit (Office of Biobank Education and Research). 

Associate Professor, Yong Loo Lin School of Medicine

Dr Tan Soo Yong obtained his medical qualifications from the National University of Singapore and thereafter underwent postgraduate training in Forensic Pathology and Histopathology in Singapore and in the University of Sheffield, United Kingdom. Qualifying in both forensic and histopathology, he is a Fellow of the Royal College of Pathologists (UK) and a Diplomate of the Society of Apothecaries of London. Dr Tan obtained his PhD from Oxford University, working in the field of haematopathology.

Co-Director, Centre for Cancer Research; Sydney West Chair in Translational Cancer Research; Obstetrics, Gynaecology and Neonatology, Westmead Clinical School; The Westmead Institute for Medical Research - Gynaecological Oncology Research Group.

Professor deFazio has a long-standing commitment to translational research with an emphasis on improving treatment outcomes for women with ovarian cancer.

Dr Sonu Bhaskar is an award-winning clinician-scientist, academic neurologist and healthcare executive with a specialisation in vascular neurology and neuroradiology and a researcher with a strong focus on neurovascular imaging, (neuro)-epidemiology and health-systems. Dr Bhaskar is the Founding Director and Chair of Governance Board of NSW Brain Clot Bank.

Helen has been involved in biobanking since 2000 in her role as curator of the Cancer Society Tissue Bank at the University of Otago Christchurch, New Zealand and has a background in cancer research and diagnostic pathology. This role has required the development of all aspects of biobanking including cultural consultation for the collection, processing, storage and use of human tissue for future unspecified research, at a time when there were no roadmaps.